Description
Northpond Ventures is a science-driven venture capital firm advancing science for the benefit of humanity. The firm builds and supports breakthrough science and technology driven businesses to create a marked impact on humanity, positioning itself as an entrepreneurial and hands-on teammate to the innovators it backs. Its portfolio includes numerous science and biotech companies, several of which have gone public (e.g., NASDAQ: MASS, CAMP, CADL, KYTX, TBIO, VIGL) or been acquired by larger organizations such as Best Buy, Eli Lilly, SCIEX, Donaldson, Unchained Labs, Labcorp, Bruker, OraSure Technologies, Innovaccer, and Vizgen, indicating a focus on life sciences and healthcare-related clients and ventures.